+关注
Yogiman
暂无个人介绍
IP属地:未知
4
关注
0
粉丝
0
主题
0
勋章
主贴
热门
Yogiman
2021-08-13
Lemonade go for it
2 Tech Stocks With 96% to 140% Upside, According to Wall Street
Yogiman
2021-07-30
Too expensive
抱歉,原内容已删除
Yogiman
2021-07-30
Worrying 😟
Goldman Sachs has been super-bullish on the global economy, but not anymore. Here's why.
Yogiman
2021-07-20
Will market crash?
抱歉,原内容已删除
Yogiman
2021-07-19
Inflation worries ahead ....
抱歉,原内容已删除
Yogiman
2021-07-17
Yeah true[笑哭]
U.S. to allow temporary rise in impurities in anti-smoking drug
Yogiman
2021-07-17
Will it affect share price
Pfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content
Yogiman
2021-07-16
Should have more details
Dow gives up earlier gain, loses 150 points despite strong retail sales
Yogiman
2021-07-16
Nice to read article
Textron added to Goldman's Conviction Buy List on business jet strength
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4089547899638310","uuid":"4089547899638310","gmtCreate":1626447708603,"gmtModify":1626487441380,"name":"Yogiman","pinyin":"yogiman","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":4,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.28","exceedPercentage":"60.80%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.28","exceedPercentage":"93.57%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":897077805,"gmtCreate":1628865581207,"gmtModify":1631884033650,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Lemonade go for it","listText":"Lemonade go for it","text":"Lemonade go for it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/897077805","repostId":"2159291893","repostType":4,"repost":{"id":"2159291893","pubTimestamp":1628864400,"share":"https://www.laohu8.com/m/news/2159291893?lang=&edition=full","pubTime":"2021-08-13 22:20","market":"us","language":"en","title":"2 Tech Stocks With 96% to 140% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2159291893","media":"Motley Fool","summary":"Analysts see big gains for Coinbase and Lemonade shareholders.","content":"<p>As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That being said, price targets can be a good place to find inspiration, and there's no harm in glancing at these figures -- provided you do your own research, too.</p>\n<p>With that in mind, Wall Street analysts see significant upside for <b>Coinbase Global</b> (NASDAQ:COIN) and <b>Lemonade</b> (NYSE:LMND). Let's look at both of these tech stocks.</p>\n<h2>Coinbase Global: 140% implied upside</h2>\n<p>Coinbase helps its clients participate in the cryptoeconomy. Its platform offers a range of products to 68 million users, including retail investors, financial institutions, and ecosystem partners. Of course, brokerage services are the core business, but there's a lot more to Coinbase.</p>\n<p>For instance, its platform also allows individuals to send, spend, borrow, and lend cryptocurrency, and it offers a cold storage solution to institutional clients. Coinbase also provides blockchain analytics tools to law enforcement, application-building tools to developers, and payment processing tools to merchants.</p>\n<p>As of the most recent quarter, Coinbase had $180 billion in assets on its platform, or 11.2% of all crypto assets, making it the market leader. That immense scale demonstrates the company's trusted brand, and it creates an opportunity for further monetization. With those advantages in mind, analysts at D.A. Davidson value Coinbase stock at $650 per share, a 140% premium to its current price.</p>\n<p>Financially, Coinbase is growing at a shocking pace -- but investors should consider these metrics with caution. Transaction fees comprise the vast majority of revenue, and those fees depend on trading volume, which has historically been highly correlated with the price of <b>bitcoin</b> and the volatility of crypto assets. And so far this year, the crypto market has been incredibly volatile, juicing monthly transacting users and revenue.</p>\n<table>\n <thead>\n <tr>\n <th><p>Metric</p></th>\n <th><p>Q2 2020 (TTM)</p></th>\n <th><p>Q2 2021 (TTM)</p></th>\n <th><p>CAGR</p></th>\n </tr>\n </thead>\n <tbody>\n <tr>\n <td width=\"156\"><p>Monthly transacting users</p></td>\n <td width=\"156\"><p>1.5 million</p></td>\n <td width=\"156\"><p>8.8 million</p></td>\n <td width=\"156\"><p>487%</p></td>\n </tr>\n <tr>\n <td width=\"156\"><p>Revenue</p></td>\n <td width=\"156\"><p>$633.8 million</p></td>\n <td width=\"156\"><p>$4.9 billion</p></td>\n <td width=\"156\"><p>678%</p></td>\n </tr>\n </tbody>\n</table>\n<p>Data source: Coinbase SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rates.</p>\n<p>Before buying Coinbase stock, investors should ask themselves <a href=\"https://laohu8.com/S/AONE.U\">one</a> question: Is cryptocurrency here to stay? If you think the answer is no, forget this stock. But if you see a future for cryptocurrency -- either as a store of value or a transactional medium -- then Coinbase could be a good way to tap into that trend.</p>\n<h2>Lemonade: 96% implied upside</h2>\n<p>Lemonade is a tech company that's disrupting the $5 trillion insurance industry. Specifically, the company uses big data and artificial intelligence to manage many aspects of its business, from quantifying risk and underwriting policies to processing claims and engaging clients.</p>\n<p>This differentiates it from traditional insurance providers, the vast majority of which rely on human brokers and agents. More to the point, many of today's industry leaders were founded over a century ago, long before the digital era, and their businesses simply weren't built to collect and deploy the types of data captured by Lemonade.</p>\n<p>This advantage should make Lemonade's platform faster, cheaper, and more precise over time, creating a flywheel effect that strengthens as the company adds more clients. With that in mind, analysts at Piper Sandler value Lemonade at $163 per share, representing 96% upside compared to its current price.</p>\n<p>Investors shouldn't fool themselves -- disrupting a well-established industry is rarely easy, and Lemonade has a long road ahead. However, the company's early financial results show promise. In Q2 2021, in-force premium (i.e. the annualized sum of customer premiums) reached $296.8 million, up 312% from Q2 2019. Over the same period, Lemonade has added new customers quickly, driving strong growth in gross profit.</p>\n<table>\n <thead>\n <tr>\n <th><p>Metric</p></th>\n <th><p>Q2 2019 (TTM)</p></th>\n <th><p>Q2 2021 (TTM)</p></th>\n <th><p>CAGR</p></th>\n </tr>\n </thead>\n <tbody>\n <tr>\n <td width=\"156\"><p>Customers</p></td>\n <td width=\"156\"><p>442,752</p></td>\n <td width=\"156\"><p>1.2 million</p></td>\n <td width=\"156\"><p>65%</p></td>\n </tr>\n <tr>\n <td width=\"156\"><p>Gross profit</p></td>\n <td width=\"156\"><p>$5.7 million</p></td>\n <td width=\"156\"><p>$26.5 million</p></td>\n <td width=\"156\"><p>116%</p></td>\n </tr>\n </tbody>\n</table>\n<p>Data source: Lemonade SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.</p>\n<p>Looking ahead, investors should pay attention to Lemonade's gross loss ratio (i.e. the percentage of premiums paid out in claims). This metric assesses how effectively an insurance company estimates risk and prices policies. For reference, Lemonade aims to keep its average loss ratio below 75% on a multi-year basis. If that number starts trending the wrong direction, it could be a red flag.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Tech Stocks With 96% to 140% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Tech Stocks With 96% to 140% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 22:20 GMT+8 <a href=https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159291893","content_text":"As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That being said, price targets can be a good place to find inspiration, and there's no harm in glancing at these figures -- provided you do your own research, too.\nWith that in mind, Wall Street analysts see significant upside for Coinbase Global (NASDAQ:COIN) and Lemonade (NYSE:LMND). Let's look at both of these tech stocks.\nCoinbase Global: 140% implied upside\nCoinbase helps its clients participate in the cryptoeconomy. Its platform offers a range of products to 68 million users, including retail investors, financial institutions, and ecosystem partners. Of course, brokerage services are the core business, but there's a lot more to Coinbase.\nFor instance, its platform also allows individuals to send, spend, borrow, and lend cryptocurrency, and it offers a cold storage solution to institutional clients. Coinbase also provides blockchain analytics tools to law enforcement, application-building tools to developers, and payment processing tools to merchants.\nAs of the most recent quarter, Coinbase had $180 billion in assets on its platform, or 11.2% of all crypto assets, making it the market leader. That immense scale demonstrates the company's trusted brand, and it creates an opportunity for further monetization. With those advantages in mind, analysts at D.A. Davidson value Coinbase stock at $650 per share, a 140% premium to its current price.\nFinancially, Coinbase is growing at a shocking pace -- but investors should consider these metrics with caution. Transaction fees comprise the vast majority of revenue, and those fees depend on trading volume, which has historically been highly correlated with the price of bitcoin and the volatility of crypto assets. And so far this year, the crypto market has been incredibly volatile, juicing monthly transacting users and revenue.\n\n\n\nMetric\nQ2 2020 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nMonthly transacting users\n1.5 million\n8.8 million\n487%\n\n\nRevenue\n$633.8 million\n$4.9 billion\n678%\n\n\n\nData source: Coinbase SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rates.\nBefore buying Coinbase stock, investors should ask themselves one question: Is cryptocurrency here to stay? If you think the answer is no, forget this stock. But if you see a future for cryptocurrency -- either as a store of value or a transactional medium -- then Coinbase could be a good way to tap into that trend.\nLemonade: 96% implied upside\nLemonade is a tech company that's disrupting the $5 trillion insurance industry. Specifically, the company uses big data and artificial intelligence to manage many aspects of its business, from quantifying risk and underwriting policies to processing claims and engaging clients.\nThis differentiates it from traditional insurance providers, the vast majority of which rely on human brokers and agents. More to the point, many of today's industry leaders were founded over a century ago, long before the digital era, and their businesses simply weren't built to collect and deploy the types of data captured by Lemonade.\nThis advantage should make Lemonade's platform faster, cheaper, and more precise over time, creating a flywheel effect that strengthens as the company adds more clients. With that in mind, analysts at Piper Sandler value Lemonade at $163 per share, representing 96% upside compared to its current price.\nInvestors shouldn't fool themselves -- disrupting a well-established industry is rarely easy, and Lemonade has a long road ahead. However, the company's early financial results show promise. In Q2 2021, in-force premium (i.e. the annualized sum of customer premiums) reached $296.8 million, up 312% from Q2 2019. Over the same period, Lemonade has added new customers quickly, driving strong growth in gross profit.\n\n\n\nMetric\nQ2 2019 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nCustomers\n442,752\n1.2 million\n65%\n\n\nGross profit\n$5.7 million\n$26.5 million\n116%\n\n\n\nData source: Lemonade SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.\nLooking ahead, investors should pay attention to Lemonade's gross loss ratio (i.e. the percentage of premiums paid out in claims). This metric assesses how effectively an insurance company estimates risk and prices policies. For reference, Lemonade aims to keep its average loss ratio below 75% on a multi-year basis. If that number starts trending the wrong direction, it could be a red flag.","news_type":1},"isVote":1,"tweetType":1,"viewCount":343,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806845452,"gmtCreate":1627651505676,"gmtModify":1633757435529,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Too expensive","listText":"Too expensive","text":"Too expensive","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/806845452","repostId":"1161272388","repostType":4,"isVote":1,"tweetType":1,"viewCount":167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806846344,"gmtCreate":1627651396688,"gmtModify":1633757437507,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Worrying 😟","listText":"Worrying 😟","text":"Worrying 😟","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/806846344","repostId":"2155137729","repostType":4,"repost":{"id":"2155137729","pubTimestamp":1627647756,"share":"https://www.laohu8.com/m/news/2155137729?lang=&edition=full","pubTime":"2021-07-30 20:22","market":"us","language":"en","title":"Goldman Sachs has been super-bullish on the global economy, but not anymore. Here's why.","url":"https://stock-news.laohu8.com/highlight/detail?id=2155137729","media":"MarketWatch","summary":"Goldman Sachs has prided itself on its bullish stance on the global economy, with its above-consensu","content":"<p>Goldman Sachs has prided itself on its bullish stance on the global economy, with its above-consensus takes doing better than many of its banking rivals to forecast just how resilient consumers and businesses have been.</p>\n<p>The gross domestic product data released Thursday show the world's largest economy, the U.S., has already surpassed its pre-pandemic peak in the second quarter.</p>\n<p>But...</p>\n<p>Goldman Sachs economists Daan Struyven and Sid Bhushan explain the bank's economics team has now become less enthusiastic. They've cut economic growth projections for the low-vaccination Asian economies including India and Australia but also the U.S. -- even while upgrading Brazil and Mexico forecasts -- taking their global growth forecast for this year to 6.4%, which is only 0.3% above the Wall Street consensus.</p>\n<p><img src=\"https://static.tigerbbs.com/efafcbb409cc58c4236521501a1f3e8f\" tg-width=\"700\" tg-height=\"341\" width=\"100%\" height=\"auto\"></p>\n<p>The more transmissible delta strain of coronavirus implies a slower recovery because of renewed outbreaks. The issue isn't just government restrictions, but also the choices of individuals to limit high-contact services.</p>\n<p>\"The share of Americans reporting to 'always avoid' high-contact activities has decreased, but remains substantial at around 50% for public transportation and large events, and 30% for travel,\" they said, citing YouGov data. \"A further recovery will require not only rising vaccinations and related medical improvements, but also time for individuals to become more comfortable.\"</p>\n<p><img src=\"https://static.tigerbbs.com/72d09db3e3c3223ebe3f95b0d81180af\" tg-width=\"700\" tg-height=\"465\" width=\"100%\" height=\"auto\"></p>\n<p>And the U.S. is grouped into <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the low-risk aversion countries, based on the restrictions imposed relative to fatalities. \"China's high risk aversion could keep quarantines and travel controls in place for longer, and delay the recovery in tourism economies such as Vietnam, Thailand, and Singapore,\" they say.</p>\n<p>The pessimism comes amid a new report from the Centers for Disease Control and Prevention, arguing the delta variant as as transmissible as chickenpox.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs has been super-bullish on the global economy, but not anymore. Here's why.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs has been super-bullish on the global economy, but not anymore. Here's why.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-30 20:22 GMT+8 <a href=https://www.marketwatch.com/story/goldman-sachs-has-been-super-bullish-on-the-global-economy-but-not-anymore-heres-why-11627641051?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Goldman Sachs has prided itself on its bullish stance on the global economy, with its above-consensus takes doing better than many of its banking rivals to forecast just how resilient consumers and ...</p>\n\n<a href=\"https://www.marketwatch.com/story/goldman-sachs-has-been-super-bullish-on-the-global-economy-but-not-anymore-heres-why-11627641051?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.marketwatch.com/story/goldman-sachs-has-been-super-bullish-on-the-global-economy-but-not-anymore-heres-why-11627641051?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2155137729","content_text":"Goldman Sachs has prided itself on its bullish stance on the global economy, with its above-consensus takes doing better than many of its banking rivals to forecast just how resilient consumers and businesses have been.\nThe gross domestic product data released Thursday show the world's largest economy, the U.S., has already surpassed its pre-pandemic peak in the second quarter.\nBut...\nGoldman Sachs economists Daan Struyven and Sid Bhushan explain the bank's economics team has now become less enthusiastic. They've cut economic growth projections for the low-vaccination Asian economies including India and Australia but also the U.S. -- even while upgrading Brazil and Mexico forecasts -- taking their global growth forecast for this year to 6.4%, which is only 0.3% above the Wall Street consensus.\n\nThe more transmissible delta strain of coronavirus implies a slower recovery because of renewed outbreaks. The issue isn't just government restrictions, but also the choices of individuals to limit high-contact services.\n\"The share of Americans reporting to 'always avoid' high-contact activities has decreased, but remains substantial at around 50% for public transportation and large events, and 30% for travel,\" they said, citing YouGov data. \"A further recovery will require not only rising vaccinations and related medical improvements, but also time for individuals to become more comfortable.\"\n\nAnd the U.S. is grouped into one of the low-risk aversion countries, based on the restrictions imposed relative to fatalities. \"China's high risk aversion could keep quarantines and travel controls in place for longer, and delay the recovery in tourism economies such as Vietnam, Thailand, and Singapore,\" they say.\nThe pessimism comes amid a new report from the Centers for Disease Control and Prevention, arguing the delta variant as as transmissible as chickenpox.","news_type":1},"isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171713003,"gmtCreate":1626763657102,"gmtModify":1633771248774,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Will market crash?","listText":"Will market crash?","text":"Will market crash?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171713003","repostId":"1140799023","repostType":4,"isVote":1,"tweetType":1,"viewCount":251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173761340,"gmtCreate":1626687771980,"gmtModify":1633924930335,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Inflation worries ahead ....","listText":"Inflation worries ahead ....","text":"Inflation worries ahead ....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/173761340","repostId":"1111084715","repostType":4,"isVote":1,"tweetType":1,"viewCount":282,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179152166,"gmtCreate":1626495851555,"gmtModify":1633926228333,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Yeah true[笑哭] ","listText":"Yeah true[笑哭] ","text":"Yeah true[笑哭]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/179152166","repostId":"2152485685","repostType":4,"repost":{"id":"2152485685","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1626481445,"share":"https://www.laohu8.com/m/news/2152485685?lang=&edition=full","pubTime":"2021-07-17 08:24","market":"us","language":"en","title":"U.S. to allow temporary rise in impurities in anti-smoking drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2152485685","media":"Reuters","summary":"July 16 (Reuters) - The U.S. drug regulator said on Friday it will temporarily allow manufacturers t","content":"<p>July 16 (Reuters) - The U.S. drug regulator said on Friday it will temporarily allow manufacturers to distribute the anti-smoking drug varenicline with elevated levels of an impurity that may cause cancer, to maintain availability after Pfizer Inc halted distribution of its Chantix branded varenicline.</p>\n<p>Pfizer in June halted distribution of Chantix and recalled a number of lots after finding elevated levels of nitrosamines in the pills.</p>\n<p>On Friday, it recalled 12 more lots.</p>\n<p>The Food and Drug Administration (FDA) will temporarily allow some manufacturers to distribute varenicline containing impurities above its intake limit of 37 nanograms per day, but below an interim limit of 185 ng per day, until the impurity can be eliminated or reduced to acceptable levels.</p>\n<p>The regulator said the health benefits of stopping smoking outweigh the cancer risk from the nitrosamine impurity in varenicline.</p>\n<p>Canadian generic drugmaker Apotex will be temporarily allowed to distribute Apo-Varenicline tablets in the United States to help maintain adequate varenicline supply in the country for the near term, the FDA said.</p>\n<p>The nitrosamine impurity, called N-nitroso-varenicline, may be associated with a potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication, the FDA said.</p>\n<p>Risk of exposure to the carcinogen at interim acceptable intake levels up to 185 ng per day presents minimal additional cancer risk, compared with a lifetime exposure at the 37 ng per day level, the agency said.</p>\n<p>The FDA determined that varenicline recalled by Pfizer poses an unnecessary risk to patients and recommended healthcare professionals to consider other available treatment options.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. to allow temporary rise in impurities in anti-smoking drug</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. to allow temporary rise in impurities in anti-smoking drug\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-17 08:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 16 (Reuters) - The U.S. drug regulator said on Friday it will temporarily allow manufacturers to distribute the anti-smoking drug varenicline with elevated levels of an impurity that may cause cancer, to maintain availability after Pfizer Inc halted distribution of its Chantix branded varenicline.</p>\n<p>Pfizer in June halted distribution of Chantix and recalled a number of lots after finding elevated levels of nitrosamines in the pills.</p>\n<p>On Friday, it recalled 12 more lots.</p>\n<p>The Food and Drug Administration (FDA) will temporarily allow some manufacturers to distribute varenicline containing impurities above its intake limit of 37 nanograms per day, but below an interim limit of 185 ng per day, until the impurity can be eliminated or reduced to acceptable levels.</p>\n<p>The regulator said the health benefits of stopping smoking outweigh the cancer risk from the nitrosamine impurity in varenicline.</p>\n<p>Canadian generic drugmaker Apotex will be temporarily allowed to distribute Apo-Varenicline tablets in the United States to help maintain adequate varenicline supply in the country for the near term, the FDA said.</p>\n<p>The nitrosamine impurity, called N-nitroso-varenicline, may be associated with a potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication, the FDA said.</p>\n<p>Risk of exposure to the carcinogen at interim acceptable intake levels up to 185 ng per day presents minimal additional cancer risk, compared with a lifetime exposure at the 37 ng per day level, the agency said.</p>\n<p>The FDA determined that varenicline recalled by Pfizer poses an unnecessary risk to patients and recommended healthcare professionals to consider other available treatment options.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152485685","content_text":"July 16 (Reuters) - The U.S. drug regulator said on Friday it will temporarily allow manufacturers to distribute the anti-smoking drug varenicline with elevated levels of an impurity that may cause cancer, to maintain availability after Pfizer Inc halted distribution of its Chantix branded varenicline.\nPfizer in June halted distribution of Chantix and recalled a number of lots after finding elevated levels of nitrosamines in the pills.\nOn Friday, it recalled 12 more lots.\nThe Food and Drug Administration (FDA) will temporarily allow some manufacturers to distribute varenicline containing impurities above its intake limit of 37 nanograms per day, but below an interim limit of 185 ng per day, until the impurity can be eliminated or reduced to acceptable levels.\nThe regulator said the health benefits of stopping smoking outweigh the cancer risk from the nitrosamine impurity in varenicline.\nCanadian generic drugmaker Apotex will be temporarily allowed to distribute Apo-Varenicline tablets in the United States to help maintain adequate varenicline supply in the country for the near term, the FDA said.\nThe nitrosamine impurity, called N-nitroso-varenicline, may be associated with a potential increased cancer risk in humans, but there is no immediate risk to patients taking this medication, the FDA said.\nRisk of exposure to the carcinogen at interim acceptable intake levels up to 185 ng per day presents minimal additional cancer risk, compared with a lifetime exposure at the 37 ng per day level, the agency said.\nThe FDA determined that varenicline recalled by Pfizer poses an unnecessary risk to patients and recommended healthcare professionals to consider other available treatment options.","news_type":1},"isVote":1,"tweetType":1,"viewCount":475,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":179152024,"gmtCreate":1626495809968,"gmtModify":1633926228580,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Will it affect share price","listText":"Will it affect share price","text":"Will it affect share price","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/179152024","repostId":"2152168563","repostType":4,"repost":{"id":"2152168563","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1626489317,"share":"https://www.laohu8.com/m/news/2152168563?lang=&edition=full","pubTime":"2021-07-17 10:35","market":"us","language":"en","title":"Pfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content","url":"https://stock-news.laohu8.com/highlight/detail?id=2152168563","media":"T-Reuters","summary":"Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lo","content":"<p>Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use & Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-07-17 10:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use & Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152168563","content_text":"Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use & Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).","news_type":1},"isVote":1,"tweetType":1,"viewCount":502,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170711238,"gmtCreate":1626450734324,"gmtModify":1633926599101,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Should have more details","listText":"Should have more details","text":"Should have more details","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170711238","repostId":"1140939614","repostType":4,"repost":{"id":"1140939614","pubTimestamp":1626446093,"share":"https://www.laohu8.com/m/news/1140939614?lang=&edition=full","pubTime":"2021-07-16 22:34","market":"us","language":"en","title":"Dow gives up earlier gain, loses 150 points despite strong retail sales","url":"https://stock-news.laohu8.com/highlight/detail?id=1140939614","media":"CNBC","summary":"The Dow Jones Industrial Average drifted lower Friday even as the latest retail sales numbers came o","content":"<div>\n<p>The Dow Jones Industrial Average drifted lower Friday even as the latest retail sales numbers came out better-than-expected.\nThe Dow lost 150 points, or 0.46%, after opening above 35,000. The index ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/15/stock-market-open-to-close-news.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow gives up earlier gain, loses 150 points despite strong retail sales</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow gives up earlier gain, loses 150 points despite strong retail sales\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 22:34 GMT+8 <a href=https://www.cnbc.com/2021/07/15/stock-market-open-to-close-news.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Dow Jones Industrial Average drifted lower Friday even as the latest retail sales numbers came out better-than-expected.\nThe Dow lost 150 points, or 0.46%, after opening above 35,000. The index ...</p>\n\n<a href=\"https://www.cnbc.com/2021/07/15/stock-market-open-to-close-news.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"https://www.cnbc.com/2021/07/15/stock-market-open-to-close-news.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1140939614","content_text":"The Dow Jones Industrial Average drifted lower Friday even as the latest retail sales numbers came out better-than-expected.\nThe Dow lost 150 points, or 0.46%, after opening above 35,000. The index closed just short of that level on Monday. The S&P 500 dipped around 0.2% and the Nasdaq Composite edged about 0.1% lower.\nRetail and food service salesrose 0.6% in June, while economists surveyed by Dow Jones had expected a 0.4% decline. Excluding autos, those sales jumped 1.3%, beating economists’ estimate of a 0.4% gain.\nWeaker performance from technology stocks weighed on the market. Shares of Netflix fell more than 1% ahead of the streaming giant’s second-quarter earnings report next week. Nvidia shares fell about 2%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170719296,"gmtCreate":1626450627215,"gmtModify":1633926600145,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Nice to read article","listText":"Nice to read article","text":"Nice to read article","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170719296","repostId":"1120221325","repostType":4,"repost":{"id":"1120221325","pubTimestamp":1626446001,"share":"https://www.laohu8.com/m/news/1120221325?lang=&edition=full","pubTime":"2021-07-16 22:33","market":"us","language":"en","title":"Textron added to Goldman's Conviction Buy List on business jet strength","url":"https://stock-news.laohu8.com/highlight/detail?id=1120221325","media":"seekingalpha","summary":"Textron (TXT+0.9%) opens more than 2% higher before pulling back, as Goldman Sachsadds the stock to ","content":"<ul>\n <li>Textron (TXT+0.9%) opens more than 2% higher before pulling back, as Goldman Sachsadds the stock to its Conviction Buy Listsince it is trading \"at a sizable valuation discount to other aerospace companies... and consensus estimates look too low.\"</li>\n <li>\"The business jet market continues to strengthen in a way that increasingly looks long-term sustainable, particularly in Cessna's categories of the market,\" according to Goldman's Noah Poponak.</li>\n <li>U.S. business jet flight activity is 9% above 2019 levels, and COVID-19 appears to have permanently converted many pandemic adopters of business jets, Poponak says.</li>\n <li>Morgan Stanley alsocited business jet upside in its recent upgrade of Textron shares to Overweight.</li>\n</ul>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Textron added to Goldman's Conviction Buy List on business jet strength</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTextron added to Goldman's Conviction Buy List on business jet strength\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-16 22:33 GMT+8 <a href=https://seekingalpha.com/news/3715998-textron-added-to-goldmans-conviction-buy-list-on-business-jet-strength><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Textron (TXT+0.9%) opens more than 2% higher before pulling back, as Goldman Sachsadds the stock to its Conviction Buy Listsince it is trading \"at a sizable valuation discount to other aerospace ...</p>\n\n<a href=\"https://seekingalpha.com/news/3715998-textron-added-to-goldmans-conviction-buy-list-on-business-jet-strength\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://seekingalpha.com/news/3715998-textron-added-to-goldmans-conviction-buy-list-on-business-jet-strength","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1120221325","content_text":"Textron (TXT+0.9%) opens more than 2% higher before pulling back, as Goldman Sachsadds the stock to its Conviction Buy Listsince it is trading \"at a sizable valuation discount to other aerospace companies... and consensus estimates look too low.\"\n\"The business jet market continues to strengthen in a way that increasingly looks long-term sustainable, particularly in Cessna's categories of the market,\" according to Goldman's Noah Poponak.\nU.S. business jet flight activity is 9% above 2019 levels, and COVID-19 appears to have permanently converted many pandemic adopters of business jets, Poponak says.\nMorgan Stanley alsocited business jet upside in its recent upgrade of Textron shares to Overweight.","news_type":1},"isVote":1,"tweetType":1,"viewCount":281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":897077805,"gmtCreate":1628865581207,"gmtModify":1631884033650,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Lemonade go for it","listText":"Lemonade go for it","text":"Lemonade go for it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/897077805","repostId":"2159291893","repostType":4,"repost":{"id":"2159291893","pubTimestamp":1628864400,"share":"https://www.laohu8.com/m/news/2159291893?lang=&edition=full","pubTime":"2021-08-13 22:20","market":"us","language":"en","title":"2 Tech Stocks With 96% to 140% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2159291893","media":"Motley Fool","summary":"Analysts see big gains for Coinbase and Lemonade shareholders.","content":"<p>As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That being said, price targets can be a good place to find inspiration, and there's no harm in glancing at these figures -- provided you do your own research, too.</p>\n<p>With that in mind, Wall Street analysts see significant upside for <b>Coinbase Global</b> (NASDAQ:COIN) and <b>Lemonade</b> (NYSE:LMND). Let's look at both of these tech stocks.</p>\n<h2>Coinbase Global: 140% implied upside</h2>\n<p>Coinbase helps its clients participate in the cryptoeconomy. Its platform offers a range of products to 68 million users, including retail investors, financial institutions, and ecosystem partners. Of course, brokerage services are the core business, but there's a lot more to Coinbase.</p>\n<p>For instance, its platform also allows individuals to send, spend, borrow, and lend cryptocurrency, and it offers a cold storage solution to institutional clients. Coinbase also provides blockchain analytics tools to law enforcement, application-building tools to developers, and payment processing tools to merchants.</p>\n<p>As of the most recent quarter, Coinbase had $180 billion in assets on its platform, or 11.2% of all crypto assets, making it the market leader. That immense scale demonstrates the company's trusted brand, and it creates an opportunity for further monetization. With those advantages in mind, analysts at D.A. Davidson value Coinbase stock at $650 per share, a 140% premium to its current price.</p>\n<p>Financially, Coinbase is growing at a shocking pace -- but investors should consider these metrics with caution. Transaction fees comprise the vast majority of revenue, and those fees depend on trading volume, which has historically been highly correlated with the price of <b>bitcoin</b> and the volatility of crypto assets. And so far this year, the crypto market has been incredibly volatile, juicing monthly transacting users and revenue.</p>\n<table>\n <thead>\n <tr>\n <th><p>Metric</p></th>\n <th><p>Q2 2020 (TTM)</p></th>\n <th><p>Q2 2021 (TTM)</p></th>\n <th><p>CAGR</p></th>\n </tr>\n </thead>\n <tbody>\n <tr>\n <td width=\"156\"><p>Monthly transacting users</p></td>\n <td width=\"156\"><p>1.5 million</p></td>\n <td width=\"156\"><p>8.8 million</p></td>\n <td width=\"156\"><p>487%</p></td>\n </tr>\n <tr>\n <td width=\"156\"><p>Revenue</p></td>\n <td width=\"156\"><p>$633.8 million</p></td>\n <td width=\"156\"><p>$4.9 billion</p></td>\n <td width=\"156\"><p>678%</p></td>\n </tr>\n </tbody>\n</table>\n<p>Data source: Coinbase SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rates.</p>\n<p>Before buying Coinbase stock, investors should ask themselves <a href=\"https://laohu8.com/S/AONE.U\">one</a> question: Is cryptocurrency here to stay? If you think the answer is no, forget this stock. But if you see a future for cryptocurrency -- either as a store of value or a transactional medium -- then Coinbase could be a good way to tap into that trend.</p>\n<h2>Lemonade: 96% implied upside</h2>\n<p>Lemonade is a tech company that's disrupting the $5 trillion insurance industry. Specifically, the company uses big data and artificial intelligence to manage many aspects of its business, from quantifying risk and underwriting policies to processing claims and engaging clients.</p>\n<p>This differentiates it from traditional insurance providers, the vast majority of which rely on human brokers and agents. More to the point, many of today's industry leaders were founded over a century ago, long before the digital era, and their businesses simply weren't built to collect and deploy the types of data captured by Lemonade.</p>\n<p>This advantage should make Lemonade's platform faster, cheaper, and more precise over time, creating a flywheel effect that strengthens as the company adds more clients. With that in mind, analysts at Piper Sandler value Lemonade at $163 per share, representing 96% upside compared to its current price.</p>\n<p>Investors shouldn't fool themselves -- disrupting a well-established industry is rarely easy, and Lemonade has a long road ahead. However, the company's early financial results show promise. In Q2 2021, in-force premium (i.e. the annualized sum of customer premiums) reached $296.8 million, up 312% from Q2 2019. Over the same period, Lemonade has added new customers quickly, driving strong growth in gross profit.</p>\n<table>\n <thead>\n <tr>\n <th><p>Metric</p></th>\n <th><p>Q2 2019 (TTM)</p></th>\n <th><p>Q2 2021 (TTM)</p></th>\n <th><p>CAGR</p></th>\n </tr>\n </thead>\n <tbody>\n <tr>\n <td width=\"156\"><p>Customers</p></td>\n <td width=\"156\"><p>442,752</p></td>\n <td width=\"156\"><p>1.2 million</p></td>\n <td width=\"156\"><p>65%</p></td>\n </tr>\n <tr>\n <td width=\"156\"><p>Gross profit</p></td>\n <td width=\"156\"><p>$5.7 million</p></td>\n <td width=\"156\"><p>$26.5 million</p></td>\n <td width=\"156\"><p>116%</p></td>\n </tr>\n </tbody>\n</table>\n<p>Data source: Lemonade SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.</p>\n<p>Looking ahead, investors should pay attention to Lemonade's gross loss ratio (i.e. the percentage of premiums paid out in claims). This metric assesses how effectively an insurance company estimates risk and prices policies. For reference, Lemonade aims to keep its average loss ratio below 75% on a multi-year basis. If that number starts trending the wrong direction, it could be a red flag.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Tech Stocks With 96% to 140% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Tech Stocks With 96% to 140% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-13 22:20 GMT+8 <a href=https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2021/08/13/tech-stocks-96-to-140-upside-wall-street-coinbase/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159291893","content_text":"As a long-term investor, I tend to ignore near-term price targets. Instead, I look for stocks I can hold for at least five years, and preferably longer if my investment thesis remains intact. That being said, price targets can be a good place to find inspiration, and there's no harm in glancing at these figures -- provided you do your own research, too.\nWith that in mind, Wall Street analysts see significant upside for Coinbase Global (NASDAQ:COIN) and Lemonade (NYSE:LMND). Let's look at both of these tech stocks.\nCoinbase Global: 140% implied upside\nCoinbase helps its clients participate in the cryptoeconomy. Its platform offers a range of products to 68 million users, including retail investors, financial institutions, and ecosystem partners. Of course, brokerage services are the core business, but there's a lot more to Coinbase.\nFor instance, its platform also allows individuals to send, spend, borrow, and lend cryptocurrency, and it offers a cold storage solution to institutional clients. Coinbase also provides blockchain analytics tools to law enforcement, application-building tools to developers, and payment processing tools to merchants.\nAs of the most recent quarter, Coinbase had $180 billion in assets on its platform, or 11.2% of all crypto assets, making it the market leader. That immense scale demonstrates the company's trusted brand, and it creates an opportunity for further monetization. With those advantages in mind, analysts at D.A. Davidson value Coinbase stock at $650 per share, a 140% premium to its current price.\nFinancially, Coinbase is growing at a shocking pace -- but investors should consider these metrics with caution. Transaction fees comprise the vast majority of revenue, and those fees depend on trading volume, which has historically been highly correlated with the price of bitcoin and the volatility of crypto assets. And so far this year, the crypto market has been incredibly volatile, juicing monthly transacting users and revenue.\n\n\n\nMetric\nQ2 2020 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nMonthly transacting users\n1.5 million\n8.8 million\n487%\n\n\nRevenue\n$633.8 million\n$4.9 billion\n678%\n\n\n\nData source: Coinbase SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rates.\nBefore buying Coinbase stock, investors should ask themselves one question: Is cryptocurrency here to stay? If you think the answer is no, forget this stock. But if you see a future for cryptocurrency -- either as a store of value or a transactional medium -- then Coinbase could be a good way to tap into that trend.\nLemonade: 96% implied upside\nLemonade is a tech company that's disrupting the $5 trillion insurance industry. Specifically, the company uses big data and artificial intelligence to manage many aspects of its business, from quantifying risk and underwriting policies to processing claims and engaging clients.\nThis differentiates it from traditional insurance providers, the vast majority of which rely on human brokers and agents. More to the point, many of today's industry leaders were founded over a century ago, long before the digital era, and their businesses simply weren't built to collect and deploy the types of data captured by Lemonade.\nThis advantage should make Lemonade's platform faster, cheaper, and more precise over time, creating a flywheel effect that strengthens as the company adds more clients. With that in mind, analysts at Piper Sandler value Lemonade at $163 per share, representing 96% upside compared to its current price.\nInvestors shouldn't fool themselves -- disrupting a well-established industry is rarely easy, and Lemonade has a long road ahead. However, the company's early financial results show promise. In Q2 2021, in-force premium (i.e. the annualized sum of customer premiums) reached $296.8 million, up 312% from Q2 2019. Over the same period, Lemonade has added new customers quickly, driving strong growth in gross profit.\n\n\n\nMetric\nQ2 2019 (TTM)\nQ2 2021 (TTM)\nCAGR\n\n\n\n\nCustomers\n442,752\n1.2 million\n65%\n\n\nGross profit\n$5.7 million\n$26.5 million\n116%\n\n\n\nData source: Lemonade SEC filings. TTM = trailing-12-months. CAGR = compound annual growth rate.\nLooking ahead, investors should pay attention to Lemonade's gross loss ratio (i.e. the percentage of premiums paid out in claims). This metric assesses how effectively an insurance company estimates risk and prices policies. For reference, Lemonade aims to keep its average loss ratio below 75% on a multi-year basis. If that number starts trending the wrong direction, it could be a red flag.","news_type":1},"isVote":1,"tweetType":1,"viewCount":343,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179152166,"gmtCreate":1626495851555,"gmtModify":1633926228333,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Yeah true[笑哭] ","listText":"Yeah true[笑哭] ","text":"Yeah true[笑哭]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/179152166","repostId":"2152485685","repostType":4,"isVote":1,"tweetType":1,"viewCount":475,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":806845452,"gmtCreate":1627651505676,"gmtModify":1633757435529,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Too expensive","listText":"Too expensive","text":"Too expensive","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/806845452","repostId":"1161272388","repostType":4,"isVote":1,"tweetType":1,"viewCount":167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":173761340,"gmtCreate":1626687771980,"gmtModify":1633924930335,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Inflation worries ahead ....","listText":"Inflation worries ahead ....","text":"Inflation worries ahead ....","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/173761340","repostId":"1111084715","repostType":4,"isVote":1,"tweetType":1,"viewCount":282,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":806846344,"gmtCreate":1627651396688,"gmtModify":1633757437507,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Worrying 😟","listText":"Worrying 😟","text":"Worrying 😟","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/806846344","repostId":"2155137729","repostType":4,"isVote":1,"tweetType":1,"viewCount":389,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170719296,"gmtCreate":1626450627215,"gmtModify":1633926600145,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Nice to read article","listText":"Nice to read article","text":"Nice to read article","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170719296","repostId":"1120221325","repostType":4,"isVote":1,"tweetType":1,"viewCount":281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":179152024,"gmtCreate":1626495809968,"gmtModify":1633926228580,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Will it affect share price","listText":"Will it affect share price","text":"Will it affect share price","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/179152024","repostId":"2152168563","repostType":4,"repost":{"id":"2152168563","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"T-Reuters","id":"1086160438","head_image":"https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5"},"pubTimestamp":1626489317,"share":"https://www.laohu8.com/m/news/2152168563?lang=&edition=full","pubTime":"2021-07-17 10:35","market":"us","language":"en","title":"Pfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content","url":"https://stock-news.laohu8.com/highlight/detail?id=2152168563","media":"T-Reuters","summary":"Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lo","content":"<p>Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use & Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Issues Voluntary Nationwide Recall For Twelve Lots Of Chantix Tablets Due To N-Nitroso Varenicline Content\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086160438\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a113a995fbbc262262d15a5ce37e7bc5);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">T-Reuters </p>\n<p class=\"h-time\">2021-07-17 10:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use & Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2152168563","content_text":"Pfizer Inc:Pfizer Issues A Voluntary Nationwide Recall For Twelve Lots Of Chantix® (Varenicline) Tablets Due To N-Nitroso Varenicline Content.Wholesalers, Distributors With Existing Inventory Of The Lots Should Stop Use & Distribution; Quarantine The Product Immediately.Pfizer-Recalling 2 Lots Of Chantix 0.5Mg, 2 Lots Of Chantix 1 Mg Tablets, 8 Lots Of Chantix Kit Of 0.5Mg/1 Mg Tablets Due To Presence Of Nitrosamine.Believes The Benefit/Risk Profile Of Chantix Remains Positive.To Date, Pfizer Has Not Received Any Reports Of Adverse Events That Have Been Related To This Recall.As Communicated By Fda, There Is No Immediate Risk To Patients Taking Chantix.Further Company Coverage:. ((Reuters.Briefs@Thomsonreuters.Com;)).","news_type":1},"isVote":1,"tweetType":1,"viewCount":502,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170711238,"gmtCreate":1626450734324,"gmtModify":1633926599101,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Should have more details","listText":"Should have more details","text":"Should have more details","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/170711238","repostId":"1140939614","repostType":4,"isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171713003,"gmtCreate":1626763657102,"gmtModify":1633771248774,"author":{"id":"4089547899638310","authorId":"4089547899638310","name":"Yogiman","avatar":"https://static.tigerbbs.com/9da3026816d2d7223cd50a9dd90b7476","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089547899638310","idStr":"4089547899638310"},"themes":[],"htmlText":"Will market crash?","listText":"Will market crash?","text":"Will market crash?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171713003","repostId":"1140799023","repostType":4,"isVote":1,"tweetType":1,"viewCount":251,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}